All treatments
Treatment
Ritlecitinib 100 mg clinical trials
2 indexed studies · 1 currently recruiting
- RecruitingPHASE3
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
This study is looking at two different strengths (50mg and 100mg) of a medicine called ritlecitinib for people aged 12 and over with alopecia areata. It aims to understand how safe and effective the 100mg dose is for hair regrowth.
For: Alopecia AreataUnited States · Canada · China - Active not recruitingPHASE3
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
This study looks at a medicine called ritlecitinib for non-segmental vitiligo, a skin condition causing white patches. It checks how safe and effective the medicine is and if it keeps working or helps more. People who were in an earlier study can join this one.
For: VitiligoUnited States · Australia · Bulgaria